|
Market Closed -
Nasdaq
16:30:00 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 3.790 USD | +2.99% |
|
+11.70% | -83.08% |
Evolution of the Average Target: Revelation Biosciences, Inc.
Evolution of the Target Price: Revelation Biosciences, Inc.
Changes in Analyst Recommendations: Revelation Biosciences, Inc.
d6693516b2d18dbe9aa623ca34ee9.vDHIBNsXd6CNcZzlezp-QlOAid4quM8-HuS1Lx-MGTc.hV6lVZd_T8qgIqWKDgokDSS0xoFb2odnUIX9Akn2cQT4A7h3q14i970p-w~e0b34add31ee6ad97d8a19c21a294662
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | +3,178.37% | ||||
| +32.59% | |||||
| +28.09% | |||||
| +10.26% | |||||
| +8.34% | |||||
| +15.58% | |||||
| +38.43% | |||||
| +38.53% | |||||
| +31.23% | |||||
| +4.99% | |||||
| Average | +338.64% | |||||
| Weighted average by Cap. | +23.37% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
3.790USD
Average target price
124.25USD
Spread / Average Target
+3,178.37%
High Price Target
136.50USD
Spread / Highest target
+3,501.58%
Low Price Target
112.00USD
Spread / Lowest Target
+2,855.15%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- REVB Stock
- Consensus Revelation Biosciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
